Drug for Multiple Myeloma Demonstrated to Significantly Extend Disease-Free Survival (National Institutes of Health)

Automated News - Automated News

User Rating: / 0
PoorBest 
Initial results from a large, randomized clinical trial for patients with multiple myeloma, a cancer of the blood and bone marrow, showed that patients who received the oral drug lenalidomide (Revlimid, also known as CC-5013) following a blood stem cell transplant had their cancer kept in check longer than patients who received a placebo.

Read more: Yahoo! News Search Results for Multiple Myeloma

Comments (0)
Only registered users can write comments!

Users Online

We have 28 guests and 0 members online
No users online.

Recent Forum Topics

  • 02/17/2010 06:57 Thanx (admin)
  • 02/16/2010 11:42 Thanx (UFCRuleZ)
 

Social Bookmark

RSS Syndicator

Feed
Feed

Search Articles

Gallery Preview



Polls

How did you find us?
 

Polls

Did you have a Stem Cell Transplant?
 

Visitors Counter

mod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_countermod_vvisit_counter
mod_vvisit_counterToday344
mod_vvisit_counterYesterday788
mod_vvisit_counterThis week2453
mod_vvisit_counterLast week731
mod_vvisit_counterThis month2599
mod_vvisit_counterLast Month19085
mod_vvisit_counterAll96300

Online (20 minutes ago): 17
Your IP: 38.107.191.102
,
Now is: 2010-03-10 11:36
JoomlaWatch Stats 1.2.9 by Matej Koval



Copyright © 2010 Myeloma Forums. - All Rights Reserved